Howard University Hospital, previously known as Freedmen's Hospital, is a major hospital located in Washington, D.C., built on the site of the previous Griffith Stadium.

There are 300 beds in Howard University Hospital.

During the past decade, Howard University Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 14 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Howard University Hospital" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 27 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Georgetown University" with 3 trials sponsored and "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Howard University Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 15 trials as a collaborator, "National Cancer Institute (NCI)" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "Glaxo Wellcome" with 5 trials as a collaborator and "Howard University" with 5 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Howard University Hospital" are "HIV Infections" (29 trials), "Sickle Cell Disease" (13 trials), "Pregnancy" (7 trials), "Prostate Cancer" (5 trials) and "Pulmonary Hypertension" (4 trials). Many other conditions were trialed in "Howard University Hospital" in a lesser frequency.

Most popular intervention types in "Howard University Hospital" are "Drug" (57 trials), "Other" (17 trials), "Biological" (10 trials), "Behavioral" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (11 trials), "Placebo" (10 trials), "Didanosine" (7 trials), "Lamivudine" (6 trials) and "Nevirapine" (6 trials). Other intervention names were less common.

The vast majority of trials in "Howard University Hospital" are 83 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Howard University Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Howard University Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Howard University Hospital, 10 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".